| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/12/264:05 PM | -$0.05 | -$0.05GAAP | 0.0% | +17% | — | $0 | — | — | |
| Q2 '26 | 8/11/264:00 PM | -$0.04 | -$0.05GAAP | -25.0% | +29% | — | $0 | — | — | |
| Q1 '26 | 5/12/264:05 PM | -$0.06 | -$0.05GAAP | +16.7% | +29% | — | $0 | — | — | |
| Q4 '25 | 3/19/264:05 PM | -$0.06 | -$0.05GAAP | +16.7% | +38% | — | $0 | — | — | |
| Q3 '25 | 11/12/254:00 PM | -$0.08 | -$0.06GAAP | +25.0% | +40% | — | $0 | — | — | |
| Q2 '25 | 8/12/254:00 PM | -$0.08 | -$0.07GAAP | +12.5% | +46% | — | $0 | — | — | |
| Q1 '25 | 5/13/254:00 PM | -$0.11 | -$0.07GAAP | +36.4% | +67% | — | $0 | — | — |
GAAP = diluted EPS as filed with the SEC.